APLM Stock Analysis: Buy, Sell, or Hold?
$25.00
1.09 (4.56%)
â˛
5d:
+4.08%
30d:
+2.77%
90d:
+9.51%
WAIT
LOW Confidence
Analysis Updated: Sep 21, 2026 12:00 AM ET
Earnings: Jul 24, 2026
0d
Get Alerted When APLM Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: APLM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: APLM is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: APLM is currently trading at $25.00, which is considered fair relative to its 30-day fair value range of $23.08 to $26.44.
Technical Outlook: Technically, APLM is in a strong uptrend. Immediate support is located at $21.21, while resistance sits at $27.37. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: APLM scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $2.00. Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, APLM is in a strong uptrend. Immediate support is located at $21.21, while resistance sits at $27.37. The stock is showing strong short-term momentum, up 4.6% recently.
Market Sentiment: APLM scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. However, the stock is trading significantly above the average Wall Street target of $2.00. Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$23.08 -
$26.44
Company Quality Score
45/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
44.7%
All Signals
- NEUTRAL: Price in fair range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Strong upward momentum (+4.6%)
- BEARISH: Trading 91.6% above Wall St target ($2.00)
- WARNING: Composite score 45/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$23.08 -
$26.44
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$21.21
Resistance Level
$27.37
Current Trend
Strong Uptrend
Technical data as of
Sep 21, 2026
Fundamental Context
Wall Street Target
$2.00
(-91.6%)
Revenue Growth (YoY)
380.8%
Profit Margin
-123.7%
Share & Embed Analysis
Last updated: September 22, 2026 10:41 AM ET
Data refreshes hourly during market hours. Next update: 11:41 AM
Data refreshes hourly during market hours. Next update: 11:41 AM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is APLM showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RARE
Ultragenyx |
STRONG BUY
20 analysts |
$28 | 57 HOLD |
|
IONS
Ionis Pharmaceuticals Inc |
BUY
26 analysts |
$84 | 53 HOLD |
|
ACLX
Arcellx Inc |
STRONG BUY
18 analysts |
$113 | 50 HOLD |
|
RCKT
Rocket Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$9 | 50 HOLD |
|
APLS
Apellis Pharmaceuticals âĻ |
BUY
22 analysts |
$41 | 50 HOLD |